Interestingly, through ROC and ULR analysis of four genes, we found that the combination of IFIT2, IFIT3, RSAD2, and PARP14 may potentially act as a novel biomarker for SSc-PAH. This evidence concerns the gene IFIT2 and systemic sclerosis.